Immunomodulatory agent plus corticosteroid

0 marketed 2 in Phase 3

This page covers all Immunomodulatory agent plus corticosteroid drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Cereblon (CRBN), glucocorticoid receptor, Cereblon (CRBN); glucocorticoid receptor.

Targets

Cereblon (CRBN), glucocorticoid receptor · Cereblon (CRBN); glucocorticoid receptor

Phase 3 pipeline (2)

Thalidomide plus dexamethasone · Grupo de Estudos Multicentricos em Onco-Hematologia · Oncology
Thalidomide acts as an immunomodulatory agent and cereblon E3 ligase ligand, while dexamethasone provides corticosteroid-mediated anti-inflammatory and immunosuppressive effects.
CC-5013 plus dexamethasone · Celgene · Oncology
CC-5013 (lenalidomide) is an immunomodulatory agent that enhances T-cell proliferation and cytokine production while dexamethasone provides corticosteroid-mediated anti-inflammatory and anti-proliferative effects.